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capacity to generate T-cell clones when cultured in limiting dilutions. CFU-TL nature of these cells was also confirmed by the sequential expression of mature T-cell specific markers on their surface after in vitro induction. This BM subset also contained 2% to 3% CFU-GM precursors. Together, these results pointed to the existence of BM CD7+CD2-precursors with high differentiation potential and showed the commitment of most of them to T-cell lineage. 0 1990 by The American Society of Hematology.
OKMl (CDllb), OKM13 (CD13) (Ortho Pharmaceuticals, Raritan, NJ); LEU-M3 (CD14) (Becton-Dickinson, Grenoble, France); IOB4 (CD19) (Immunotech, Marseille, France); RFT2a (CD7), RFT8 (CD8), RFTl2 (CD6), RFHLA-DR (a gift from G. Janossy, Royal Free Hospital, London, UK)"; MY9 (CD33) (Coulter Clones, Margency, France); MY 10 (CD34, a gift from C. Civin, The Johns Hopkins Oncology Center, Baltimore, MD)I2; UCHTl (CD3t) (a gift from P.C.L. Beverley, Oxford University, UK)"; BMA031 (TcRaP) and 6C2 (TcRy) (a gift from F. Triebel, Institut Gustave Roussy, Villejuif, France)I4; 6TCS1 (TcRG) (T Cell Sciences, Cambridge, MA). Various cell subsets are tested for the presence of surface antigens by indirect immunofluorescence and simultaneous staining with ethidium bromide for viable cell distinction using FACStar (Becton Dickinson). Cell markers were also evaluated by ultraviolet microscope (Leitz Orthoplan, Rueil, France). In the latter case, more than 200 viable cells were scored for each point. Freshly isolated cells or individual colonies were also transferred on glass slides, air dried, fixed with formalin, and stained with the above-mentioned MoAb. For double labeling, IOT7-fluoresceine (CD7-FITC, Immunotech), T2H9-phycoerythrin (CD2-PE, Coulter Clones) were used. In these experiments, MsIgG-PE and MsIgG-FITC (Coulter Clones) were used as negative controls.
Normal human BM samples were obtained from patients undergoing total hip replacement" or normal volunteers with their consent. Mononuclear cells were isolated by FicollHypaque gradient. As the number of the precursors studied was very limited, only BM with more than lo9 mononuclear cells were selected for the following experiments. Adherent cells were removed by plastic surface adherence. CD2+ T lymphocytes were then removed by E-rosetting using AET-(aminoethylisothiouronium bromide hydrobromide, Sigma, Chesnes, France) treated sheep red blood cells (RBCs). Further mature T-cell elimination and precursor cell enrichment were achieved by incubating E-cells with a combination of the following rabbit complement-fixing MoAb: OKTII, OKT3, OKT4, RFT8, RFT12, LEU-M3, OKM13, and IOB4. These MoAbs were previously tested for the absence of nonspecific toxicity on human CFU-TL and granulo-monocytic colony forming unit (CFU-GM). Two treatment cycles were then applied with 4-week-old rabbit C'. Before positive selection of CD7+ cells, another plastic adherence procedure was applied to eliminate residual adherent cells. Thereafter, the immunoadherence (panning) method was applied as described el~ewhere.~.'~ Briefly, 50-mL plastic flasks were treated overnight with RFT2a MoAb at 4°C; the flasks were then washed twice with Hank's balanced salt solution. Nonadherent T-cell-depleted BM cells were added to the flaiks (107/flask) and incubated for 90 minutes at 4OC. Negative cells were removed by gentle washing and positive cells were collected using a sterile rubber policeman. This procedure led to more than 90% viable cell recovery (range 82% to 96%) of both positive and negative fractions. For these studies, only cell preparations with less than 1% viable T cells were used, as assessed by their positivity for CD2, CD3, CD4, and/or Cell preparation.
CD8 with a negativity for simultaneous staining with ethidium bromide.
Limiting dilution method" was used to assay the cloning ability of various cell subsets. Briefly, BM cells were suspended (0.5 to 40/well, 400 wells per titration point) in modified MacCoy's 5A medium" containing 20% AB serum, phytohemagglutinin-M (PHA-M, 100 pg/mL, Difco, Detroit, MI), recombinant interleukin-2 (rIL-2,100 U/mL, Biogen, Basel, Switzerland), irradiated (3,000 rad) autologous E-BM cells, and 10% PHA-induced leukocyte-conditioned medium (PHA-LCM). Our preliminary results pointed to the importance of above culture medium for optimal growth of T-cell precursors. Estimated frequencies were obtained by fitting the experimental data according to the statistical method described by Porter and Berry." When optimal culture conditions were used, a fit to limiting dilution theory was obtained.
Conditioned media used in this study were 3-day supernatants of PHA-stimulated nonadherent non-T cells recovered from peripheral blood leukocytes as described
We have previously shown that these preparations support in vitro T-cell differentiati~n.~.~ When needed, residual PHA was removed by adsorption on chicken RBCs, according to Alvarez et a]." CD7+ cell preparations (5. 10S/mL) were also cultured in medium containing 20% AB serum and PHA-LCM. The cells were then harvested every 24 hours to study the evolution of their surface markers. Simultaneously, viability of the cells was analyzed by ethidium bromide exclusion and cell growth was assessed by tritiated thymidine uptake. In these culture conditions, 96% to 150% of the cells were recovered and cell viability exceeded 87%. We have previously shown that cell augmentation is due to the residual PHA.9 Indeed, cell number did not increase when PHA-free supernatants were used (data not shown).
CFU-GM assay. BM cell preparations were also assayed for their ability to generate myeloid colonies in double layered agar
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cultures as described e1se~here.l~ Feeder layers contained 15% AB serum, rIL-3 (100 U/mL) or rGM-CSF (100 U/mL) (10' U/mg, a kind gift of Biogen). BM-derived precursors were also cultured in limiting dilution in the presence of recombinant granulocytemacrophage colony-stimulating factor (rGM-CSF) or rIL-3 and irradiated autologous cells, and cloning frequencies were calculated as described above.
RESULTS
Marker analysis of enriched CD7+ subset. Using cell separation methods described above, we obtained relatively homogeneous cell fraction of highly enriched CD7+ cells (Fig 1) . Fluorescence activated cell sorter (FACS) analysis indicated that CD7-expressing cells comprised 0.1% of the number of total Ficoll-isolated BM cells before treatment. The CD7+-enriched population showed light scatter profile corresponding to small lymphoid cells (Fig 1) . Table 1 shows further surface markers of freshly isolated fractions. Most of these cells (greater than 80%) express CD7 and are negative for surface CD2, CD3, CD4, CD8, TcRa, 8, y, and 6 chains.
Only a low percentage of these cells contain intracytoplasmic CD3e. No mature B or T cells were detected, and about 6% of CD7+ cells express CD34. We also failed to detect glycophorin A (AGA), CD16, CD19, and CD33 on these cells (data not shown). Our cell preparations also contained a small proportion of CD7-cells. Most of these cells have monocytic morphology. Nevertheless, regarding the low number of CD7-cells, our results indicated that the cell separation method used above permitted high enrichment of CD7 +CD2-CD3-precursors.
We assayed the capacity of highly enriched CD7+2-subset to In addition, cloning capacity was completely abolished when these cells were treated with anti-CD7 and C before cultures (Fig 2) . Together these data indicate that colony precursors were CD7+. Cell nature of the growing clones was assayed by phenotypic analysis of individual colonies and pooled colony cells on day 14 postincubation. Table 2 shows that most colonies contain CD2+CD3+TcRa@+TcRy& cells (range 88% to 97% of colonies). Fifty-nine percent of the colonies were CD4+ and 22% were CD8+, and no double positive (CD4+CD8+) colonies or cells were observed. In these cultures, no significant myeloid or B-cell clones were observed (less than 2%).
We also performed limiting dilution analysis of CD7+ cells cultured in the presence of rIL-3 and rGM-CSF. The same cell preparations were also seeded in semi-solid cultures for CFU-GM enumeration. As shown in Table 3 , only a low proportion of these cells generate in vitro myeloid clones in limiting dilution as compared with CFU-TL capacity. When cultured in agar, less than 1/250 cloning frequencies were observed, which is less significant than cloning frequencies were observed, which is less significant than cloning frequencies observed in limiting dilution cultures (1/35). Most of these colonies had myeloid colony morphology. Furthermore, for T-cell cloning we did not observe colonies from CD7+ cell-depleted fractions (data not shown). Together these findings indicate that CD7+CD2-precursors contained very low CFU-GM capacity as compared with their CFU-TL potential.
Kinetics of in vitro acquisition of mature T-cell antigens by CD7+CD2-cells. We have previously shown' that no growth could be observed without PHA and rIL-2 addition. Thus we assayed the in vitro effect of PHA-LCM alone on CD7+CD2-precursors. Purified CD7+CD2-cells were incubated with or without PHA-LCM, and surface antigens were analyzed every day post-culture. Viable cell number and cell growth were controlled during the incubation period and are shown in Fig 3. When these precursors were incubated in the absence of PHA-LCM (Fig 4A) , CD7 antigen showed a rapid modulation2' at the first 24 hours, probably due to CD7 triggering during panning procedure.
CD7+ precursors display low CFU-GM capacity. CD7 was rapidly re-expressed thereafter. Neither of other mature T-cell antigens were re-expressed during this incubation period, confirming the absence of these determinants on the surface of CD7+ precursors. By contrast, when these cells were incubated with PHA-LCM (Fig 4B) , a sequential appearance of mature T-cell surface antigens was observed. CD2 appeared very early, followed by CD3, CD4, and/or CD8. In addition, they mostly expressed TcRao chains (69.94% 7.6% on day 5) and the proportion of TcRy6 cells remained very low (less than 3% on day 5).
DISCUSSION
In this study, a minor subset of CD7+CD2-CD3-cells was highly enriched from normal human BM and was also shown to comprise most early CFU-TL precursors. These cells failed to proliferate in response to PHA and/or IL-2, nor were they able to express mature T-cell antigens after in vitro short-term culture in medium alone. Their high CFU-TL potential was confirmed by their ability to acquire mature T-cell antigens and to generate T-cell clones soon after appropriate in vitro conditioning. They required PHA-LCM for mature T-cell antigen expression and PHA, rIL-2, and irradiated autologous cells to generate mature T-cell clones. Although CD7+ cells seem to be mostly committed to T-cell lineage, a limited number of CFU-GM was also detected in these cell preparations. This study corroborates previous reports on the possible phenotypic characteristics of human early T-cell precurs o r~.~-~* " Using negative selection, Bodger et al" suggested that these precursors were RFBI+CD7+TdT+. Studies on the leukemia counterpart of human prothymocytes showed that CD7 expression preceded other T-cell specific antigend2 as well as TcRa, @, and y gene rearrange~nent.~.~ We previously reported the presence of RFBl TD3-TdT-Tcell precursors in peripheral blood lymphocyte (PBL)-derived cultures.23 CD7+CD2-cells were also detected in human postnatal t h y m~s~.~~ as well as early fetal life.6 Fetal precursors, like adult BM-derived CD7+CD2-cells, had the ability to generate mature T-cell colonies when incubated with PHA-induced T-cell supernatants and rIL-2. 6 These findings raised the question of whether these cells were the candidates for migration to the thymus, as predicted from fetal studies.6 Experiments in progress using molecular TcR analysis should help to define the homology between these BM CD7TD2-CD3-T-cell precursors and their thymic counterpart. The commitment of all CD7+ precursors to T-cell lineage remains to be established. Only 47% of isolated cells were able to generate T-cell clones in limiting dilutions. W e also detected, although in a limited number, CFU-GM from these cell preparations. These precursors, as with CFU-TL, are abolished after CD7+ cell killing (data not shown). Myeloid precursor capacity of normal CD7+ prothymocytes was recently but the cloning frequencies obtained from these studies were below 1/200. This is very low in comparison with the 1/2.1 CFU-TL and 1/35 CFU-GM frequencies observed in this study. Thus, it remains possible that CD7+ cells, and in particular the CD34' subset:' also contain few myeloid precursors. We can therefore conclude that a high proportion of these precursors, but not all, were committed to T-cell lineage.
Finally, as the BM-derived CD7+CD2-subset had the in vitro ability to rapidly acquire expression of new T-cell antigens as well as TcRaO, they may represent a good in vitro tool to study normal T-cell differentiation.
